Escherichia coli Nissle 1917 Protects Intestinal Barrier Function by Inhibiting NF-κ B-Mediated Activation of the MLCK-P-MLC Signaling Pathway
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Escherichia coli Nissle 1917 (EcN), a kind of probiotic, has been reported to have a protective effect on the intestinal barrier function and can ameliorate certain gastrointestinal disorders. In this study, the potential protective effect of EcN on the intestinal barrier function in a septic mouse model induced by cecal ligation and puncture (CLP) operation was investigated. FITC-Dextran 4,000 Da (FD-4) flux and the expression levels of tight junction (TJ) proteins were measured to evaluate the protective effect of EcN on the intestinal barrier function. Then, Caco-2 monolayers were utilized to further investigate the protective effect of the EcN supernatant (EcN sup) on the barrier dysfunction induced by TNF-α and IFN-γ in vitro; the plasma level of both the cytokines increased significantly during sepsis. Transepithelial electrical resistance (TEER) and FD-4 transmembrane flux were measured, and the localization of ZO-1 and Occludin was investigated by immunofluorescence. The expression of MLCK and the phosphorylation of MLC were detected by western blot. The activation of NF-κ B was explored by immunofluorescence, and CHIP assays were performed to investigate the conjunction of NF-κ B with the promoter of MLCK. The results indicated that EcN protected the intestinal barrier function in sepsis by ameliorating the altered expression and localization of TJ proteins and inhibiting the NF-κ B-mediated activation of the MLCK-P-MLC signaling pathway which might be one of the mechanisms underlying the effect of EcN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, EcN may interact with the intestinal epithelium to stimulate anti-inflammatory activities24, as well as to restore and maintain intestinal barrier function25.”
From Developing a new class of engineered live bacterial therapeutics to treat human diseases (2020) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952 · cited 2×
“Broadly speaking, the normal intestinal barrier consists of the epithelial barrier, immune barrier, mucus barrier, and microecological barrier [5, 6].”
Immune modulation by bacterial outer membrane vesicles
Kaparakis-Liaskos, M., & Ferrero, R. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3837 · Cited by 1,019
Wang, F., Graham, W. V., Wang, Y., Witkowski, E. D., Schwarz, B. T., & Turner, J. R. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62264-x · Cited by 696
Action of cytochalasin D on cytoskeletal networks.
Schliwa, M. (1982) · The Journal of cell biology · doi:10.1083/jcb.92.1.79 · Cited by 585
Ma, T. Y., Boivin, M. A., Ye, D., Pedram, A., & Said, H. M. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00412.2004 · Cited by 452
The Gut as the Motor of Multiple Organ Dysfunction in Critical Illness
Klingensmith, N. J., & Coopersmith, C. M. (2016) · Critical Care Clinics · doi:10.1016/j.ccc.2015.11.004 · Cited by 417
Ye, D., Ma, I., & Ma, T. Y. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00318.2005 · Cited by 393
Myosin light chain kinase: pulling the strings of epithelial tight junction function
Cunningham, K. E., & Turner, J. R. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06526.x · Cited by 345 · cited 1×
“Previous studies indicated that the increased expression of MLCK induced by TNF-α/IFN-γ was mediated by NF-κB p65 signaling [22, 37].”
MicroRNA Regulation of Intestinal Epithelial Tight Junction Permeability
Ye, D., Guo, S., Al–Sadi, R., & Ma, T. Y. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.005 · Cited by 306
Self-citationAl-Sadi, R., Guo, S., Ye, D., & Ma, T. Y. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.09.001 · Cited by 262
Self-citation
Cited by
Developing a new class of engineered live bacterial therapeutics to treat human diseases
Charbonneau, M. R., Isabella, V. M., Li, N., & Kurtz, C. B. (2020) · Nature Communications · doi:10.1038/s41467-020-15508-1 · Cited by 523
The Potential Impact of Probiotics on Human Health: An Update on Their Health-Promoting Properties
Maftei, N.-M., Raileanu, C. R., Balta, A. A., Ambrose, L., Boev, M., Marin, D. B., & Lisa, E. L. (2024) · Microorganisms · doi:10.3390/microorganisms12020234 · Cited by 381
Chen, H., Lei, P., Ji, H., Yang, Q., Peng, B., Ma, J., Fang, Y., Qu, L., Li, H., Wu, W., et al. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100543 · Cited by 120
Self-citationAdolfsen, K. J., Callihan, I., Monahan, C. E., Greisen, P. J., Spoonamore, J. E., Momin, M. M., Fitch, L. E., Castillo, M. J., Weng, L., Renaud, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26524-0 · Cited by 110
Kropp, C., Corf, K. L., Relizani, K., Tambosco, K., Martinez, C., Chain, F., Rawadi, G., Langella, P., Claus, S. P., & Martín, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-90885-1 · Cited by 120
Haque, M., Kaminsky, L. W., Abdulqadir, R. F., Engers, J., Kovtunov, E. A., Rawat, M., Al–Sadi, R., & Ma, T. Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1348010 · Cited by 87
Imidacloprid increases intestinal permeability by disrupting tight junctions
Zhao, G., Wang, X., Li, J., Wang, R., Ren, F., Pang, G., & Li, Y. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112476 · Cited by 76
Hu, Z.-Y., Yang, S.-J., Chang, Y., Wang, X., Liu, R.-Q., Jiang, F., Chen, M., Wang, J.-X., Liu, S., Zhu, H., et al. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.136095 · Cited by 73
Probiotics and the intestinal tight junction barrier function
Ferris, M. M., Antonio, L. S., & Al–Sadi, R. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1671152 · Cited by 77
Wu, H., Wei, J., Zhao, X., Liu, Y., Chen, Z., Wei, K., Lu, J., Chen, W., Jiang, M., Li, S., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10351 · Cited by 63
“EcN and EcN-GLP-1, the level of colon inflammation dropped significantly compared to that of exenatide, which means that the better therapeutic effects might benefit more from the probiotic properties of EcN.(35,39) Tight junction proteins such as ZO-1 and occludin play a vital role in maintaining the intestinal barri…”
BackgroundInfluentialSelf-citationTeng, G., Li, H., Liu, Y., Wu, T., Dai, Y., Wang, H., & Wang, W. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.819336 · Cited by 59
Self-citationNative and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases
Shen, H., Zhao, Z., Zhao, Z., Chen, Y., & Zhang, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020594 · Cited by 58
Guo, S., Li, J., Huang, Z., Yue, T., Zhu, J., Wang, X., Liu, Y., Wang, P., & Chen, S.-W. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01681-7 · Cited by 44
“Immunofluorescence (IF) AP-1 and NF-κB expression in cells was evaluated by immunofluorescence as described previously [27].”
MethodSelf-citationEfficacy of Probiotics in Reducing Pathogenic Potential of Infectious Agents
Vinayamohan, P. G., Joseph, D., Viju, L. S., Baskaran, S. A., & Venkitanarayanan, K. (2024) · Fermentation · doi:10.3390/fermentation10120599 · Cited by 61
Gao, J., Cao, S., Xiao, H., Hu, S., Yao, K., Huang, K., Jiang, Z., & Wang, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.897395 · Cited by 39
Perreault, M., Means, J., Gerson, E., James, M., Cotton, S. L., Bergeron, C. G., Simon, M. D., Carlin, D. A., Schmidt, N., Moore, T. C., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.01.005 · Cited by 39
Direct Action of Non-Digestible Oligosaccharides against a Leaky Gut
Mavrogeni, M. E., Asadpoor, M., Henricks, P. A. J., Keshavarzian, A., Folkerts, G., & Braber, S. (2022) · Nutrients · doi:10.3390/nu14214699 · Cited by 38
Possible Role of Vitamin D in Celiac Disease Onset
Vici, G., Camilletti, D., & Polzonetti, V. (2020) · Nutrients · doi:10.3390/nu12041051 · Cited by 40
“In particular, MLCK phosphorylates MLC, which is a mediator of actin dynamics, thus leading to a contraction of the actomyosin cytoskeleton and disruption of TJs in the intestine [54].”
BackgroundFalzone, L., Lavoro, A., Candido, S., Salmeri, M., Zanghì, A., & Libra, M. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2397874 · Cited by 35
Physiological activity of E. coli engineered to produce butyric acid
Park, Y., Kim, T., Ham, J., Choi, J., Lee, H., Yeon, Y. J., Choi, S. I., Kim, N., Kim, Y.-R., & Seok, Y. (2021) · Microbial Biotechnology · doi:10.1111/1751-7915.13795 · Cited by 30
“Although butyric acid helped to lower the IL-6 levels in the MG1655 strains, the IL-6 levels in EcN were reduced by other metabolites, such as microcin M and TepC protein (Guo et al., 2019; Jo et al., 2019).”
BackgroundWang, F., Wang, D., Song, M., Zhou, Q., Liao, R., & Wang, Y. (2019) · Current Eye Research · doi:10.1080/02713683.2019.1707229 · Cited by 24
Wu, B., Wu, M., Liu, Y. S., Lu, M., Guo, J., Yun-hui, M., & Zhou, Y. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00366.2020 · Cited by 24
Self-citationMicrobiome-liver crosstalk: A multihit therapeutic target for liver disease
Kirundi, J., Moghadamrad, S., & Urbaniak, C. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i11.1651 · Cited by 26
“In vitro treatment of Caco-2 cells with the probiotic E. coli Nissle 1917 increases the expression and peripheral migration of ZO-2[32].”
Surface-functionalized bacteria: Frontier explorations in next-generation live biotherapeutics
Jiang, J.-N., Kong, F., Lei, Q., & Zhang, X. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.123029 · Cited by 26
Engineered Probiotics Mitigate Gut Barrier Dysfunction Induced by Nanoplastics
Chen, W., Guo, Q., Li, H., Chi, X., Ma, X., Tang, Y., Liang, Q., Liu, Z., Liu, Y., & Li, J. (2025) · Advanced Science · doi:10.1002/advs.202417283 · Cited by 28
Self-citationEscherichia coli - Old and New Insights
Erjavec, M. S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95203 · Cited by 25
Damoogh, S., Vosough, M., Hadifar, S., Rasoli, M., Gorjipour, A., Falsafi, S., & Behrouzi, A. (2021) · BMC Research Notes · doi:10.1186/s13104-021-05568-x · Cited by 19
“Also, it has a positive effect on the expression (up-regulation) of zonula occludens (ZO) proteins (namely, ZO-1 and ZO-2) and thus repairing leaky gut phenomena [28].”
BackgroundXiao, L., Dou, W., Wang, Y., Deng, H., Xu, H., & Pan, Y. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115752 · Cited by 18
Self-citationAbdulqadir, R. F., Al–Sadi, R., Haque, M. R., Gupta, Y., Rawat, M., & Ma, T. Y. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.05.012 · Cited by 19
Xu, H., Hou, Q., Zhu, J., Feng, M., Wang, P., & Pan, Y. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120330 · Cited by 14
Self-citationEl‐Saadony, M. T., Saad, A. M., Sitohy, M. Z., Alkafaas, S. S., Dladla, M., Ghosh, S., Mohammed, D. M., Ibrahim, E. H., Fahmy, M. A., Elkelish, A., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1713426 · Cited by 22
Trasciatti, S., & Grizzi, F. (2024) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2023.12.004 · Cited by 16
The Role of Intestinal Flora in Anti-Tumor Antibiotic Therapy
Ye, X., Wang, A., Lin, W., Xu, Y., Dong, X., Zhou, Y., Tian, K., & Xu, X. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2710281 · Cited by 16
“It can also inhibit nuclear factor kappa-B (NF-κ B)-mediated MLCK-P-MLC signaling pathway [26] to protect the intestinal epithelial barrier and reduce intestinal permeability.”
BackgroundLai, Y., Tang, W., Luo, X., Zheng, H., Zhang, Y., Wang, M., Yu, G., & Yang, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1369116 · Cited by 17
“Treatment with the R. gnavus or the B. uniformis bacterial supernatant increased the tight junction protein ZO-1, in line with studies showing that the Escherichia coli Nissle supernatant increased the ZO-1 mRNA to protect the intestinal barrier (44).”
ResultHeer, K., Kaur, M., Sidhu, D., Dey, P., & Raychaudhuri, S. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1452784 · Cited by 12
Zhan, X., Chen, W., Chen, J., Lei, C., & Wei, L. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.1c00159 · Cited by 12
Therapeutic manipulation of the microbiome in liver disease
Parthasarathy, G., Malhi, H., & Bajaj, J. S. (2024) · Hepatology · doi:10.1097/hep.0000000000000987 · Cited by 15
Wang, Y., Deng, H., Xiao, L., & Pan, Y. (2024) · Microorganisms · doi:10.3390/microorganisms12081622 · Cited by 11
“Our previous studies have confirmed EcN’s protective effects against intestinal barrier injury induced by the incurrence of sepsis [9–11].”
ResultSelf-citationPu, Y., Qian, F., Guo, J., Sha, Y., & Yi-ming, Q. (2022) · Neurotoxicity Research · doi:10.1007/s12640-021-00448-5 · Cited by 11
“Escherichia coli Nissle 1917 (EcN) protects intestinal barrier function in a septic mouse model by inhibiting the NF-κB/MLCK/p-MLC signaling pathway (Guo et al. 2019).”
BackgroundKempf, F., Drumo, R., Chaussé, A., Menanteau, P., Kubasová, T., Roche, S., Lalmanach, A.-C., Guabiraba, R., Chaumeil, T., Larivière-Gauthier, G., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2474151 · Cited by 9
Unveiling the Therapeutic Potential of Probiotics in Sepsis: A Review
Wang, Z., Huang, J., & Zhao, P. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70364 · Cited by 6
Duan, Y., Deng, Y., Tang, F., & Li, J. (2024) · Aging · doi:10.18632/aging.205692 · Cited by 8
“Lifibrate inhibited the activation of MLCK/p-MLC signaling against OGD/R in bEnd.3 cells MLCK/p-MLC signaling is claimed as a critical pathway that mediates the expression of TJ proteins [28]. bEnd.3 cells were exposed to the OGD/R condition with or without Lifibrate (6 μM).”
MethodPrevotella melaninogenica disrupted oral epithelial barrier function via myosin light chain kinase
Guo, Y., Han, W., & He, Y. (2024) · Oral Diseases · doi:10.1111/odi.14980 · Cited by 5
Nofouzi, K., Sheikhzadeh, N., Hamidian, G., Shahbazfar, A. A., Soltani, M., & Marandi, A. (2024) · Fish Physiology and Biochemistry · doi:10.1007/s10695-024-01366-x · Cited by 4
“In humans, EcN improves gut immunity, ulcerative colitis and allergic reactions as well as strengthening the tight junctions of the intestinal barrier, thus reducing infection via the gut (Zyrek et al. 2007; Trebichavsky et al. 2010; Losurdo et al. 2015; Guo et al. 2019).”
Potential of Escherichia coli Probiotics for Improved Health and Disease Management
Gattupalli, N., & Gattupalli, A. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.100380 · Cited by 8
“Additionally, EcN prevents disruption of epithelial tight junctions by inhibiting NF-κB-mediated activation of the MLCK-P-MLC signaling pathway [28].”
BackgroundHuang, X., Pan, M., Du, P., Chen, Y., Zhang, C., Wang, L., & Lin, J. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-6438 · Cited by 4
“Moreover, a previous study showed that Escherichia coli nissle 1917 preserves the function of the intestinal barrier by restraining NF-κB-regulated activation of the myosin light chain kinase (MLCK) signaling pathway (64).”
Resultdos Santos, V. R., de Carvalho, G. O., & Silva, J. B. N. F. (2021) · Microbiology Research · doi:10.3390/microbiolres12030039 · Cited by 3
Yordanova, M., Zhang, X., Torres, C. B., Evison, S. E. F., Gill, R. J., & Graystock, P. (2025) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiaf080 · Cited by 2
“Yet, under different conditions, E. coli can also aid its host in utilising important nutrients (Sewell et al. 2018 ) and reduce infections with other intestinal pathogens (Guo et al. 2019 , Eberl et al. 2021 ).”
Recombinant live biotherapeutics and synthetic biology: Recent advancement and perspective
Murjani, K., Solanki, D., & Singh, V. (2026) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2026.01.004 · Cited by 2
Sinelnikov, M. Y., Sankova, M. V., Nikolenko, V. N., Oganesyan, M. V., Bakhmet, А. А., Gavryushova, L. V., & Sankov, S. V. (2022) · Current Drug Targets · doi:10.2174/1389450123666220418094853 · Cited by 2
Probiotic: An Uprising Human Health Concept
Bhatt, A. R., Kothari, D. R., Kothari, C., & Kothari, R. K. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98828 · Cited by 4
Genetic and Epigenetic Regulation by Gut Microbe-Modulated Metabolites in Chronic Metabolic Diseases
Sumi, S., & Kartha, C. C. (2022) · Springer eBooks · doi:10.1007/978-981-16-7672-7_5 · Cited by 1
Tang, Z., Zhu, Y., Hu, X., Lui, K. Y., Li, S., Song, X., Cai, C.-J., & Guan, X. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01180-z · Cited by 1
Exploring the Health Benefits of Probiotics: Current Insights and Therapeutic Applications
Chandrasekaran, S., & Manoharan, K. (2026) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3485 · Cited by 1
Sankova, M. V., Nikolenko, V. N., Sankov, S. V., & Sinelnikov, M. Y. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18566-3.00023-2 · Cited by 1
Zhang, Z.-H., Xu, D.-Y., Chen, G., Teng, T., Wu, H., & Zhou, X. (2023) · 四川大学学报:医学版 · doi:10.12182/20230360503 · Cited by 3
Chassis engineering of E. coli Nissle 1917 for development of live biotherapeutics
Zainuddin, H. S. B. (2021) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-20210609-205
Impact of Metabolic Regulation in Understanding the Status of Human Health and Diseases: A Review
Siddiqui, N., Bhavana, P. L., Sarvani, V., Gurumanchi, S., Nambidi, S., Madhav, S., Reddy, G. S., Reddy, G. K., & Rao, K. (2022) · International Journal of Life Science and Pharma Research · doi:10.22376/ijpbs/lpr.2022.12.1.l19-31
Polyphenols Promote Intestinal Absorption of Lutein Both in Vivo and in VitroPreprint
lu, F., Lu, F., Zhang, Z., Xiao, Y., Nie, M., Zhou, C., Li, D., Feng, L., Dai, Z., & Xu, Y. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4864900
Prospects of probiotic Escherichia coli Nissle 1917 in the treatment of septic shock
Wang, Y., & Pan, Y. (2024) · Surgery · doi:10.1016/j.surg.2024.109031
Self-citationCellular Nanoparticle–Probiotic Biohybrid for Multimodal Oral Therapy of Food Allergy
Sun, L., Shen, W., Zhang, J. A., Yu, Y., Bai, D., Feng, K., Guo, Z., Zhou, Z., Gao, W., & Zhang, L. (2026) · ACS Nano · doi:10.1021/acsnano.5c18828
Mohammed, V., Shanmugaraja, M., & Sureshkumar, K. (2026) · Indian Journal of Psychological Medicine · doi:10.1177/02537176261420447 · Cited by 1
Biotics: The Food Ingredients Supporting the Intestinal Microbiota and Immune System in Psoriasis
Biasi, J. D., Giménez‐Bastida, J. A., & Krupa‐Kozak, U. (2026) · Nutrition Reviews · doi:10.1093/nutrit/nuaf252
Metadata
- Authors
- Guo, S., Chen, S., Ma, J., Ma, Y., Zhu, J., Ma, Y., Liu, Y., Wang, P., & Pan, Y.
- Affiliations
- Peking University (CN)
- Division of General Surgery, Peking University First Hospital, Peking University, Beijing 100034, China
- Corresponding author
- Wang, Pengyuan
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2019-07-03
- Volume
- 2019
- Pages
- 1-13
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- PMC
- PMC6636522
- OpenAlex
- W2955220684
- Cited by
- 64
- References
- 38
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 19 · 2023: 5 · 2022: 11 · 2021: 14 · 2020: 3 · 2019: 1
- FWCI
- 5.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Mediators of Inflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Keywords
- Escherichia coli Nissle 1917, probiotics, intestinal barrier function, sepsis, NF-κB signaling, tight junction proteins, ZO-1, occludin, transepithelial electrical resistance, TNF-α, interferon-gamma, cecal ligation and puncture, Caco-2 cell monolayers
- MeSH terms
- Animals, Escherichia coli, Humans, Intestinal Mucosa, Male, Mice, Inbred C57BL, Phosphorylation, Blotting, Western, Signal Transduction, NF-kappa B, Sepsis, Caco-2 Cells, Tight Junctions, Mice, Transcription Factor RelA, Tight Junction Proteins, Occludin, Zonula Occludens-1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.